Daniel KimDr. Daniel Kim joined Radiation Oncology Associates in 2021. Dr. Kim is trained in all aspects of radiation oncology with experience in advanced radiation therapy modalities including proton radiotherapy, stereotactic radiosurgery (SRS), stereotactic ablative radiotherapy (SBRT or SABR), intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), MRI-linear accelerator radiotherapy, high-dose rate (HDR) brachytherapy, low-dose rate (LDR) brachytherapy, intraoperative radiotherapy (IORT), and radioisotope/radiopharmaceutical therapy.

His clinical interests include providing high-level multidisciplinary treatment for genitourinary cancers (prostate, bladder, testicular, kidney, penile, and other urologic cancers), CNS (brain and spine) benign and malignant tumors, and gastrointestinal cancers. He is one of the only physicians in the mid-Atlantic region who offers all modalities for prostate cancer treatment in his practice (proton radiotherapy, HDR brachytherapy, LDR brachytherapy, SBRT/SABR on the Cyberknife and linear accelerator, IMRT/VMAT, MRI-guided radiotherapy, radioisotope/radiopharmaceutical therapy, and spacer gel placement). Dr. Kim’s academic interests have been in translational science through developing novel biomarkers by analysis of annotated datasets and preclinical studies that inform clinical trial design. He has developed and helped activate phase I and II clinical trials. Dr. Kim has received grant funding through the American Association for Cancer Research (AACR). He also has research interests in clinical outcomes from proton radiotherapy. He is widely published and has authored over thirty peer-reviewed publications in journals such as the New England Journal of Medicine and Clinical Cancer Research. He has been invited to present his research at national and international meetings, including AACR, American Society of Clinical Oncology (ASCO), and American Society for Radiation Oncology (ASTRO). Dr. Kim serves as a reviewer for several journals including Cancer, Journal of Urology, and Journal of Neurosurgery.

Dr. Kim graduated magna cum laude from Amherst College with degrees in neuroscience and music. He graduated cum laude with his M.D. and M.B.A. from Harvard Medical School and Harvard Business School, respectively. He was awarded the Michael E. Porter Leadership Award upon graduation and served as Senior Advisor to then-Mayor Marty Walsh, focusing on shaping economic and healthcare policy for the city of Boston and Commonwealth of Massachusetts. Dr. Kim completed his internal medicine internship at Harvard Medical School’s Brigham and Women’s Hospital. He completed his residency at the Harvard Radiation Oncology Program which included training at Massachusetts General Hospital, Dana Farber Cancer Institute, Brigham and Women’s Hospital, and Boston Children’s Hospital. He was elected Chief Resident at the Harvard Radiation Oncology Program, helping guide clinical and educational directives for the largest radiation oncology residency in the country. He continues to be actively involved in teaching medical students and residents through clinical training and research.

Dr. Kim is board certified in radiation oncology. He sees patients at the Inova Schar Cancer Institute. Outside of the clinic, Dr. Kim enjoys playing sports and spending time with his wife and children.